Citation: | SHAO Xiaoxiao, SHI Ruixin, FANG Ye, WANG Weizhong, JIANG Yi. Ustekinumab in the treatment of stenosis Crohn's disease: A case report and literature review[J]. Chinese Journal of General Practice, 2023, 21(12): 2169-2172. doi: 10.16766/j.cnki.issn.1674-4152.003315 |
[1] |
CHAN W P W, MOURAD F, LEONG R W. Crohn's disease associated strictures[J]. J Gastroenterol Hepatol, 2018, 33(5): 998-1008. doi: 10.1111/jgh.14119
|
[2] |
宋彩霞, 马强. 小肠疾病的临床特点及研究现状[J]. 中国临床研究, 2018, 31(3): 424-426.
SONG C R, MA Q. The clinical features and research status of small intestinal diseases[J]. Chinese Journal of Clinical Research, 2018, 31(3): 424-426.
|
[3] |
刁磊, 洪汝涛, 韩玮, 等. CT小肠成像与双气囊小肠镜在疑似小肠出血诊断中的临床应用[J]. 中华全科医学, 2021, 19(8): 1347-1350. doi: 10.16766/j.cnki.issn.1674-4152.002057
DIAO L, HONG R T, HAN W, et al. Clinical application of CT enterography and double-balloon enteroscopy in the diagnosis of suspected small intestinal bleeding[J]. Chinese Journal of General Practice, 2021, 19(8): 1347-1350. doi: 10.16766/j.cnki.issn.1674-4152.002057
|
[4] |
VEAUTHIER B, HORNECKER J R. Crohn's disease: diagnosis and management[J]. Am Fam Physician, 2018, 98(11): 661-669.
|
[5] |
LI J, MAO R, KURADA S, et al. Pathogenesis of fibrostenosing Crohn's disease[J]. Transl Res, 2019, 209(7): 39-54.
|
[6] |
LIN X X, QIU Y, ZHUANG X J, et al. Intestinal stricture in Crohn's disease: a 2020 update[J]. J Dig Dis, 2021, 22(7): 390-398. doi: 10.1111/1751-2980.13022
|
[7] |
WANG J, LIN S, BROWN JM, et al. Novel mechanisms and clinical trial endpoints in intestinal fibrosis[J]. Immunol Rev, 2021, 302(1): 211-227. doi: 10.1111/imr.12974
|
[8] |
MA C, JAIRATH V, CLICK B, et al. Targeting anti-fibrotic pathways in Crohn's disease: the final frontier?[J]. Best Pract Res Clin Gastroenterol, 2019, 38-39(1): 101603. DOI: 10.1016/j.bpg.2019.02.005.
|
[9] |
ALFREDSSON J, WICK M J. Mechanism of fibrosis and stricture formation in Crohn's disease[J]. Scand J Immunol, 2020, 92(6): e12990. DOI: 10.1111/sji.12990
|
[10] |
YOO J H, HOLUBAR S, RIEDER F. Fibrostenotic strictures in Crohn's disease[J]. Intest Res, 2020, 18(4): 379-401. doi: 10.5217/ir.2019.09148
|
[11] |
王革非. 克罗恩病并发肠梗阻的诊断与治疗[J]. 肠外与肠内营养, 2019, 26(1): 1-5.
WANG G F. Diagnosis and treatment of Crohn's disease complicated with intestinal obstruction[J]. Parenteral & Enteral Nutrition, 2019, 26(1): 1-5.
|
[12] |
时雯琳, 金世柱, 王丽霞, 等. 内镜下克罗恩病合并肠道狭窄治疗研究[J]. 胃肠病学和肝病学杂志, 2019, 28(8): 853-856.
SHI W L, JIN S Z, WANG L X, et al. Study of endoscopic treatment of Crohn's disease with intestinal stenosis[J]. Chinese Journal of Gastroenterology and Hepatology, 2019, 28(8): 853-856.
|
[13] |
HONAP S, MEADE S, IBRAHEIM H, et al. Effectiveness and safety of ustekinumab in inflammatory bowel disease: a systematic review and meta-analysis[J]. Dig Dis Sci, 2022, 67(3): 1018-1035. doi: 10.1007/s10620-021-06932-4
|
[14] |
AGGELETOPOULOU I, ASSIMAKOPOULOS S F, KONSTANTAKIS C, et al. Interleukin 12/interleukin 23 pathway: biological basis and therapeutic effect in patients with Crohn's disease[J]. World J Gastroenterol, 2018, 24(36): 4093-4103. doi: 10.3748/wjg.v24.i36.4093
|
[15] |
PETAGNA L, ANTONELLI A, GANINI C, et al. Pathophysiology of Crohn's disease inflammation and recurrence[J]. Biol Direct, 2020, 15(1): 23. doi: 10.1186/s13062-020-00280-5
|
[16] |
WEISSHOF R, EL JURDI K, ZMETER N, et al. Emerging therapies for inflammatory bowel disease[J]. Adv Ther, 2018, 35(11): 1746-1762. doi: 10.1007/s12325-018-0795-9
|
[17] |
MURATE K, NAKAMURA M, YAMAMURA T, et al. Ustekinumab is effective against small bowel lesions in Crohn's disease: two case reports[J]. Clin J Gastroenterol, 2021, 14(1): 129-135. doi: 10.1007/s12328-020-01242-0
|